DPP4 and cancer: Significantly, we observed that some of these biomarkers were already used for cancer risk of H. pylori-associated gastric cancer except for CD26 [49–53]; ω-3 PUFAs can be an effective agent to counteract biomarkers suggestive of cancer risk.